Delivery Order SPE2DB20D3104-SPE2DB25FV9S4
- Not listed
- The Defense Logistics Agency awarded a $15,047.95 delivery order to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count units) on August 7, 2025, with an ultimate completion date of August 8, 2025. This is a firm fixed price, non-set-aside contract that leverages AmerisourceBergen's existing pharmaceutical supply infrastructure. The place of performance is the contractor's corporate office in Conshohocken, Pennsylvania. As a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $5,352.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of DESCOVY 200-25 mg tablets in quantities of 30 units. The delivery order, which is non-set-aside and competitively awarded, is scheduled for completion by August 25, 2025, with performance to be executed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This contract represents a child delivery order under the company's larger...
- The Defense Logistics Agency awarded a delivery order valued at $15,723.83 to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count units) on August 19, 2025, with an ultimate completion date of August 20, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX, valued at $999,999,999.00 through December 2026). The delivery will be...
- The Defense Logistics Agency awarded a delivery order valued at $12,030.67 to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of DESCOVY 200-25 mg tablets (quantity: 30 units). The contract carries a firm fixed price structure with no set-aside designation, indicating competitive award status. Performance will be executed from the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 25, 2025. This delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order valued at $1,762.29 to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count units) on August 29, 2025, with completion targeted for September 2, 2025. This firm fixed-price delivery order was competitively awarded without set-aside provisions and is to be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $3,303.18 on August 28, 2025, for the supply of DESCOVY 200-25 mg tablets in quantities of 30 units. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 29, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $27,577.96 to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of DESCOVY 200-25 mg tablets in quantities of 30. This competitive award, which will be completed by August 12, 2025, represents a firm fixed-price transaction with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office...
- This delivery order, valued at $4,138.47, awards AmerisourceBergen Drug Corp the supply of DESCOVY 200-25 mg tablets in quantities of 30 units. The contract, issued by the Defense Logistics Agency under the Department of Defense, is a non-set-aside, competitively awarded delivery order with firm fixed pricing. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of August 1, 2025. This delivery order is issued as a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $9,392.88 to AmerisourceBergen Drug Corp for the supply of DESCOVY 200-25 mg tablets in quantities of 30 units. This firm fixed-price, non-set-aside contract was awarded on August 12, 2025, with an ultimate completion date of August 13, 2025. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $7,072.97 for DESCOVY 200-25 mg tablets (30-count units) on July 28, 2025, with completion targeted for July 29, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- SPE2DB20D3104Indefinite Delivery Contract
- SPE2DB20D3104-SPE2DB25FV9S4Delivery Order
The Defense Logistics Agency awarded a $8,032.69 delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of DESCOVY 200-25 mg tablets in quantities of 30 units. This is a firm fixed price, non-set-aside contract with performance scheduled for completion by August 21, 2025, and fulfillment based at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical supply vehicle extending through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor specializing in medical supply chain support for military and veteran healthcare systems. The company's substantial IDC with the Defense Logistics Agency enables it to deliver a diverse portfolio of pharmaceutical products, including brand-name and generic medications, vaccines, and specialized medical commodities across multiple therapeutic domains to support Defense Health Agency operations and other federal healthcare customers globally. This specific delivery order for DESCOVY tablets reflects the company's role in supplying antiretroviral medications and other specialized pharmaceuticals through the DLA's established pharmaceutical procurement framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.0k | 8/20/25 |